drugset / Trial / NCT03978494

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

NCT03978494

Phase 1 Withdrawn Sandoz
RandomizedCrossoverOpen-labelOther

Summary

Study to compare pharmacokinetics of tacrolimus prolonged-release (PR) capsules and Advagraf® PR capsules in stable kidney transplant patients.

Timeline

Start
2019-09-02
Primary completion
2020-05-03
Completion
2020-05-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 1 mg Oral
Subject Tacrolimus Small molecule 5 mg Oral

Indications

No indication recorded.